Mallinckrodt Publishes Studies And Earns Ease Of Use Certification For Gel
17 Sep 2024 //
PR NEWSWIRE
Mallinckrodt Announces U.S. FDA Approval of sNDA for Acthar
01 Mar 2024 //
PR NEWSWIRE
Mallinckrodt to Present New Retrospective Data on Effect of Acthar Gel
21 Mar 2023 //
PR NEWSWIRE
ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results
08 Aug 2022 //
BUSINESS WIRE
ANI Pharma Announces the Launch of Acebutolol Hydrochloride Capsules USP
03 Aug 2022 //
BUSINESSWIRE
ANI focuses on data insights to ramp up Cortrophin
24 Jun 2022 //
FIERCEPHARMA
ANI Pharmaceuticals Reports First Quarter 2022 Results
10 May 2022 //
BUSINESSWIRE
Retrospective Study on Real-World Treatment Patterns and Outcomes of Acthar Gel
28 Mar 2022 //
PRNEWSWIRE
ANI Pharma Announces Commercial Availability of Purified Cortrophin Gel
24 Jan 2022 //
BUSINESSWIRE
Purified Cortrophi Gel Available Through AllianceRx Walgreens Prime
16 Dec 2021 //
PRNEWSWIRE
ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin™ Gel
01 Nov 2021 //
PRESS RELEASE
ANI Pharmaceuticals Announces Refiling of Cortrophin sNDA with FDA
06 Jul 2021 //
BUSINESSWIRE
Glycomine’s Announces Update to Standard of Care for PMM2-CDG Patients
29 Jun 2021 //
BUSINESSWIRE
ANI Receives Refusal to File Letter from FDA for Cortrophin® Gel
29 Apr 2020 //
PR NEWSWIRE
ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL
13 Apr 2020 //
PRNEWSWIRE
Mallinckrodt Announces Publication of New Data on Acthar® Gel
04 Mar 2020 //
PR NEWSWIRE
Mallinckrodt receives SEC subpoena over Acthar gel lawsuit
06 Nov 2019 //
CNBC
Mallinckrodt hit with new charges same day as $15.4M settlement with feds
07 Jun 2019 //
FIERCE PHARMA
Mallinckrodt to settle U.S. drug marketing probe, fight kickback case
05 Jun 2019 //
REUTERS
Mallinckrodt sues the feds to fight $600M Acthar rebate bill
22 May 2019 //
FIERCE PHARMA
Mallinckrodt Lupus Ph4 Clinical Study for Acthar® Gel
23 Apr 2019 //
PR NEWSWIRE
Medicare spent $500 million on a drug after Mallinckrodt paid doctors thousands
29 Jun 2018 //
STATNEWS
Mallinckrodt pays $1.2bn for Sucampo Pharma
03 Jan 2018 //
PMLIVE
Mallinckrodt Highlights First Patients in Company-Sponsored Use of H.P. Acthar
25 May 2017 //
PR NEWSWIRE
Maker of $34,000-a-vial drug to pay $100M for allegedly preventing competition
19 Jan 2017 //
WASHINGTON POST
Mallinckrodt Will Initiate Company-Sponsored Clinical Trial of H.P. Acthar® Gel
21 Nov 2016 //
PR NEWSWIRE
ANI Pharma Closes Transaction to Acquire 2 NDAs from Merck for $75 Million
05 Jan 2016 //
PR NEWS WIRE
Mallinckrodt Study Shows Acthar® Reduces Disease Activity in Patients
09 Nov 2015 //
PR NEWS WIRE
ANI Pharmaceuticals to Acquire Two NDAs from Merck
22 Sep 2015 //
PR NEWS WIRE
Plant Extract Fights Brain Tumor, Max Planck Institute Of Psychiatry Study
16 Feb 2015 //
BIOSPACE